Cargando…
Quantification of the growth suppression of HER2+ breast cancer colonies under the effect of trastuzumab and PD-1/PD-L1 inhibitor
INTRODUCTION: Immune checkpoint blockade (ICB)-based therapy is revolutionizing cancer treatment by fostering successful immune surveillance and effector cell responses against various types of cancers. However, patients with HER2+ cancers are yet to benefit from this therapeutic strategy. Precisely...
Autores principales: | Padmanabhan, Regina, Kheraldine, Hadeel, Gupta, Ishita, Meskin, Nader, Hamad, Anas, Vranic, Semir, Al Moustafa, Ala-Eddin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769711/ https://www.ncbi.nlm.nih.gov/pubmed/36568154 http://dx.doi.org/10.3389/fonc.2022.977664 |
Ejemplares similares
-
Crosstalk between HER2 and PD-1/PD-L1 in Breast Cancer: From Clinical Applications to Mathematical Models
por: Padmanabhan, Regina, et al.
Publicado: (2020) -
Elaeagnus angustifolia Plant Extract Inhibits Epithelial-Mesenchymal Transition and Induces Apoptosis via HER2 Inactivation and JNK Pathway in HER2-Positive Breast Cancer Cells
por: Jabeen, Ayesha, et al.
Publicado: (2020) -
High-Risk HPV Oncoproteins and PD-1/PD-L1 Interplay in Human Cervical Cancer: Recent Evidence and Future Directions
por: Allouch, Soumaya, et al.
Publicado: (2020) -
The Effect of Surface-Modified Gold Nanorods on the Early Stage of Embryonic Development and Angiogenesis: Insight into the Molecular Pathways
por: Mahmoud, Nouf N., et al.
Publicado: (2021) -
Substantial cell apoptosis provoked by naked PAMAM dendrimers in HER2-positive human breast cancer via JNK and ERK1/ERK2 signalling pathways
por: Kheraldine, Hadeel, et al.
Publicado: (2021)